Shandong Pharmaceutical Glass Co Ltd - Asset Resilience Ratio
Shandong Pharmaceutical Glass Co Ltd (600529) has an Asset Resilience Ratio of 1.99% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Shandong Pharmaceutical Glass Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Shandong Pharmaceutical Glass Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Shandong Pharmaceutical Glass Co Ltd's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Shandong Pharmaceutical Glass Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Shandong Pharmaceutical Glass Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥202.19 Million | 1.99% |
| Total Liquid Assets | CN¥202.19 Million | 1.99% |
Asset Resilience Insights
- Limited Liquidity: Shandong Pharmaceutical Glass Co Ltd maintains only 1.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Pharmaceutical Glass Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Pharmaceutical Glass Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Orora Ltd
AU:ORA |
Packaging & Containers | 5.31% |
|
Zhejiang Jinsheng New Materials Co
SHE:300849 |
Packaging & Containers | 0.97% |
|
SMCG Co., Ltd.
KQ:460870 |
Packaging & Containers | 0.37% |
|
Dae Young Pkg
KO:014160 |
Packaging & Containers | 0.08% |
|
Amcor Plc
AU:AMC |
Packaging & Containers | -0.32% |
|
Pact Group Holdings Ltd
AU:PGH |
Packaging & Containers | 0.06% |
|
Pro-Pac Packaging Ltd
AU:PPG |
Packaging & Containers | 1.02% |
|
Irani Papel e Embalagem S.A
SA:RANI3 |
Packaging & Containers | 18.00% |
Annual Asset Resilience Ratio for Shandong Pharmaceutical Glass Co Ltd (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Shandong Pharmaceutical Glass Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 16.64% | CN¥1.67 Billion ≈ $244.56 Million |
CN¥10.04 Billion ≈ $1.47 Billion |
-0.37pp |
| 2024-12-31 | 17.01% | CN¥1.72 Billion ≈ $252.38 Million |
CN¥10.14 Billion ≈ $1.48 Billion |
+3.94pp |
| 2023-12-31 | 13.07% | CN¥1.22 Billion ≈ $178.22 Million |
CN¥9.32 Billion ≈ $1.36 Billion |
+0.53pp |
| 2022-12-31 | 12.54% | CN¥1.10 Billion ≈ $161.17 Million |
CN¥8.78 Billion ≈ $1.29 Billion |
+7.75pp |
| 2021-12-31 | 4.79% | CN¥307.13 Million ≈ $44.94 Million |
CN¥6.41 Billion ≈ $937.94 Million |
+0.69pp |
| 2020-12-31 | 4.10% | CN¥230.50 Million ≈ $33.73 Million |
CN¥5.62 Billion ≈ $822.59 Million |
-4.83pp |
| 2019-12-31 | 8.93% | CN¥461.84 Million ≈ $67.58 Million |
CN¥5.17 Billion ≈ $756.57 Million |
-8.11pp |
| 2018-12-31 | 17.04% | CN¥788.00 Million ≈ $115.31 Million |
CN¥4.62 Billion ≈ $676.59 Million |
-0.37pp |
| 2017-12-31 | 17.42% | CN¥728.00 Million ≈ $106.53 Million |
CN¥4.18 Billion ≈ $611.69 Million |
+12.81pp |
| 2016-12-31 | 4.61% | CN¥180.00 Million ≈ $26.34 Million |
CN¥3.90 Billion ≈ $571.31 Million |
+1.75pp |
| 2015-12-31 | 2.86% | CN¥85.00 Million ≈ $12.44 Million |
CN¥2.97 Billion ≈ $435.05 Million |
+0.48pp |
| 2014-12-31 | 2.38% | CN¥67.00 Million ≈ $9.80 Million |
CN¥2.82 Billion ≈ $412.39 Million |
-- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more